Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750982 · ClinicalTrials.gov registry record · NA
Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
A NA study, sponsored by Brown, Theodore R., M.D., MPH.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02750982: Completed NA study, sponsored by Brown, Theodore R., M.D., MPH.
NCT02750982 is a NA study that has completed, run by Brown, Theodore R., M.D., MPH. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02750982, a NA study, has completed, sponsored by Brown, Theodore R., M.D., MPH.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord injury.
Primary Outcome
Outcome measures will be completed at baseline, active-phase completion at week 8 and post-active phase week 8 (16 weeks post-start of active phase).
Interventions
- OTHER Laughter Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-08 |
| Phase | NA |
What the finished NCT02750982 record still lists
NCT02750982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Laughter Therapy is the first listed.
NCT02750982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02750982 about?
NCT02750982 is a clinical study titled "Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.". This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple scle...
What is the current status of trial NCT02750982?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-07. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02750982?
The interventions under investigation include: Laughter Therapy (OTHER).
Who is sponsoring clinical trial NCT02750982?
This trial is sponsored by Brown, Theodore R., M.D., MPH, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02750982's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia